Archives
JACC Journal series gives in-depth look at COVID-19’s impact on the heart
27 Oct, 2020 | 09:49h | UTCNews release: Journal series gives in-depth look at COVID-19’s impact on the heart – American College of Cardiology
JACC Focus Seminar 1: Coronavirus and Cardiometabolic Syndrome
JACC Focus Seminar 2: Coronavirus Historical Perspective, Disease Mechanisms, and Clinical Outcomes
JACC Focus Seminar 3: Coronavirus and Cardiovascular Disease, Myocardial Injury, and Arrhythmia
SARS-CoV-2 antibodies detectable up to seven months post COVID-19 onset
27 Oct, 2020 | 09:44h | UTC
Commentary on Twitter
Neutralizing antibodies to SARS-CoV-2 Spike RBD, 40-199 days after symptom end:
– ~90% of patients have
– ~75% of them (~68%) have high titre (>300)
– no age difference
– higher in hospital cases and males
– lower with steroidsShould last a few years.https://t.co/OYZV6gRfyA https://t.co/Zdhj3W7yGw pic.twitter.com/eTUF870q05
— ice9 (@__ice9) October 24, 2020
COVID-19 – Lessons learned and questions remaining
27 Oct, 2020 | 09:46h | UTCCOVID-19 – Lessons Learned and Questions Remaining – Clinical Infectious Diseases
Commentary on Twitter
🔥Excellent article🔥
COVID-19 – Lessons Learned and Questions Remaining@CarlosdelRio7 @davidantibiotic https://t.co/c0VG4yyJXO pic.twitter.com/7Bxn1mVttT— Antibiotic Steward Bassam Ghanem 🅱️C🆔🅿️🌟 (@ABsteward) October 26, 2020
CDC Guideline – Wastewater Surveillance System: A new public health tool to understand COVID-19 spread in a community
27 Oct, 2020 | 09:47h | UTCIntroduction: National Wastewater Surveillance System – Centers for Disease Control and Prevention
- Developing a Wastewater Surveillance Sampling Strategy
- Wastewater Surveillance Data Reporting & Analytics
- Public Health Interpretation and Use of Wastewater Surveillance Data
- Wastewater Surveillance Testing Methods
- Targeted Wastewater Surveillance at Facilities, Institutions, and Workplaces
Understanding protection from SARS-CoV-2 by studying reinfection
27 Oct, 2020 | 09:42h | UTCUnderstanding protection from SARS-CoV-2 by studying reinfection – Nature Medicine
COVID-19 antibody responses are related to the severity of symptoms
27 Oct, 2020 | 09:43h | UTCCommentaries: Studies show long-term COVID-19 immune response – CIDRAP AND COVID-19 immunity may be related to the severity of one’s symptoms, study finds – CTV News
Commentary on Twitter
A new paper @NatureMicrobiol shows the neutralizing antibody response to #SARSCoV2 is proportional to severity of illness, with longitudinal assessment, including a cohort of health care workers https://t.co/Ie4LAP8GZx @KingsCollegeLon and collaborators
— Eric Topol (@EricTopol) October 26, 2020
Perspective: It’s time to talk about Covid-19 and surfaces again
27 Oct, 2020 | 09:39h | UTCIt’s Time to Talk About Covid-19 and Surfaces Again – Wired
Commentary on Twitter
It’s Time to Talk About Covid-19 and Surfaces Again:
In the early days, we furiously scrubbed, afraid we could get sick from the virus lingering on objects and surfaces. What do we know now? https://t.co/vRdVVz6KMK via @GregoryJBarber— Ash Paul (@pash22) October 24, 2020
Covid-19: Six feet is not enough and 15 minutes is too long
27 Oct, 2020 | 09:38h | UTCSix Feet Is Not Enough and 15 Minutes Is Too Long – Medium
Review: Prospects for a safe COVID-19 vaccine
27 Oct, 2020 | 09:41h | UTCProspects for a safe COVID-19 vaccine – Science Translational Medicine
Observational study on the effectiveness of deep sedation for patients with intractable electrical storm refractory to antiarrhythmic drugs
27 Oct, 2020 | 09:34h | UTC
Commentary on Twitter
Effectiveness of deep sedation for patients with intractable electrical storm refractory to anti-arrhythmic drugs https://t.co/sY7R3rtdvF #AHAJournals @MartinsRaphae15 @EloiMarijon pic.twitter.com/7SD3epIUUi
— Circulation (@CircAHA) October 23, 2020
Randomized trial suggests rapid intermittent bolus of hypertonic saline is the best approach for the treatment of symptomatic hyponatremia
27 Oct, 2020 | 09:36h | UTC
For managing symptomatic #hyponatremia, both rapid intermittent bolus (RIB) and slow continuous infusion of hypertonic saline are safe and effective, but RIB achieves a target serum sodium sooner and needs lesser therapeutic re-lowering of serum sodium https://t.co/J4y4BbA855
— JAMA Internal Medicine (@JAMAInternalMed) October 26, 2020
ASCO Guideline Update: Selection of optimal adjuvant chemotherapy and targeted therapy for early breast cancer
27 Oct, 2020 | 09:32h | UTC
FDA Safety Alert: Avoid use of NSAIDs in pregnancy at 20 weeks or later
27 Oct, 2020 | 09:33h | UTCCommentary: FDA Expands Warning on Use of NSAIDs in Pregnancy – NEJM Journal Watch
Guideline: Airway management in adult trauma patients
27 Oct, 2020 | 09:30h | UTC
Commentary on Twitter
New WTA Algorithm on Airway Management – both prehospital and in-hospital algorithms. Now published and free open access in @TSACO_AAST ! Download full paper: https://t.co/MFxaWJzfdS pic.twitter.com/eZCdEC5Ys1
— WesternTrauma (@WesternTrauma) October 9, 2020
Consensus statement: Recommendations for hemodynamic monitoring for critically ill children
27 Oct, 2020 | 09:31h | UTC
Universal mask use could save 130,000 U.S. lives by the end of February, new study estimates
25 Oct, 2020 | 23:51h | UTCUniversal mask use could save 130,000 U.S. lives by the end of February, new study estimates – STAT
Original Study: Modeling COVID-19 scenarios for the United States – Nature Medicine
Commentary on Twitter
Universal mask use could save up to 130k lives from September 22, 2020 through the end of February 2021 in the United States and avoid the need for more strict measures to contain the spread of #COVID19. Read now: https://t.co/TKhSusVnZl @IHME_UW @SimonHayHealer pic.twitter.com/XVS4PgInhT
— Nature Medicine (@NatureMedicine) October 23, 2020
Practice Guideline: Neuromuscular blockade in patients with ARDS
27 Oct, 2020 | 09:28h | UTCNeuromuscular blockade in patients with ARDS: a rapid practice guideline – Intensive Care Medicine (free for a limited period)
Fauci says it might be time to mandate masks as Covid-19 surges across US
25 Oct, 2020 | 23:50h | UTCFauci says it might be time to mandate masks as Covid-19 surges across US – CNN
[Preprint] Randomized trial: Nitazoxanide does not improve symptoms in mild Covid-19 disease
25 Oct, 2020 | 23:46h | UTCEarly use of nitazoxanide in mild Covid-19 disease: randomized, placebo-controlled trial – medRxiv
Clinical Update: Virology, transmission, and pathogenesis of SARS-CoV-2
25 Oct, 2020 | 23:48h | UTCVirology, transmission, and pathogenesis of SARS-CoV-2 – The BMJ
Commentary on Twitter
https://twitter.com/bmj_latest/status/1320425173976256513
SARS-CoV-2 seroprevalence worldwide: a systematic review and meta-analysis
25 Oct, 2020 | 23:44h | UTC
Perspective: The race to make COVID antibody therapies cheaper and more potent
25 Oct, 2020 | 23:43h | UTCThe race to make COVID antibody therapies cheaper and more potent – Nature
Steroids boost survival of preterm babies in low-resource settings, new study finds
25 Oct, 2020 | 23:38h | UTCOriginal Study: Antenatal Dexamethasone for Early Preterm Birth in Low-Resource Countries – New England Journal of Medicine
Commentary on Twitter (thread – click for more)
🆕 clinical trial shows that dexamethasone can boost survival of premature babies when given to pregnant women at risk of preterm birth in low-resource settings
👉 https://t.co/qKvDKMkrkd pic.twitter.com/hjmf01J4B1
— World Health Organization (WHO) (@WHO) October 23, 2020
[Abstract Only] Randomized trial: Effect of Finerenone on chronic kidney disease outcomes in Type 2 diabetes
25 Oct, 2020 | 23:34h | UTCEffect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes – New England Journal of Medicine (link to abstract – $ for full-text)
Commentary: Finerenone Linked to Reduced Cardiorenal Events for Chronic Kidney Disease – HCPLive
Commentary on Twitter (thread – click for more)
‼️Effect of Finerenone on CKD outcomes in T2DM
⚡️Finerenone decreased risk of CKD progression by 18%
⚡️Finerenone decreased CV morbidity & mortality by 14%
Published in @NEJM today https://t.co/XvshpZZCK4@ASNKidney #Kidneywk pic.twitter.com/FOkxnG1enz
— Aisha Shaikh (@aishaikh) October 23, 2020
Perspective: Why COVID outbreaks look set to worsen this winter
25 Oct, 2020 | 23:41h | UTCWhy COVID outbreaks look set to worsen this winter – Nature
Related: WHO warns of tough months ahead as COVID tops 42 million – CIDRAP